Allianz Asset Management’s Immunogen Inc IMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-214,350
| Closed | -$6.36M | – | 2290 |
|
|
2023
Q4 | $6.36M | Buy |
214,350
+169,750
| +381% | +$3.38M | 0.01% | 834 |
|
|
2023
Q3 | $708K | Sell |
44,600
-9,800
| -18% | -$163K | ﹤0.01% | 1811 |
|
|
2023
Q2 | $1.03M | Buy |
54,400
+42,200
| +346% | +$498K | ﹤0.01% | 1518 |
|
|
2023
Q1 | $46.8K | Sell |
12,200
-50,000
| -80% | -$213K | ﹤0.01% | 2086 |
|
|
2022
Q4 | $309K | Sell |
62,200
-36,000
| -37% | -$195K | ﹤0.01% | 1809 |
|
|
2022
Q3 | $469K | Sell |
98,200
-322,120
| -77% | -$1.7M | ﹤0.01% | 1548 |
|
|
2022
Q2 | $1.89M | Buy |
420,320
+220,185
| +110% | +$957K | ﹤0.01% | 1435 |
|
|
2022
Q1 | $953K | Sell |
200,135
-20,760
| -9% | -$115K | ﹤0.01% | 1876 |
|
|
2021
Q4 | $1.64M | Buy |
220,895
+159,005
| +257% | +$988K | ﹤0.01% | 1692 |
|
|
2021
Q3 | $351K | Sell |
61,890
-153,575
| -71% | -$887K | ﹤0.01% | 2362 |
|
|
2021
Q2 | $1.42M | Sell |
215,465
-177,775
| -45% | -$1.24M | ﹤0.01% | 1602 |
|
|
2021
Q1 | $3.19M | Sell |
393,240
-104,025
| -21% | -$849K | ﹤0.01% | 1235 |
|
|
2020
Q4 | $3.21M | Sell |
497,265
-288,181
| -37% | -$1.68M | ﹤0.01% | 1178 |
|
|
2020
Q3 | $2.83M | Sell |
785,446
-12,474
| -2% | -$50.4K | ﹤0.01% | 1149 |
|
|
2020
Q2 | $3.67M | Buy |
797,920
+453,894
| +132% | +$1.93M | ﹤0.01% | 1337 |
|
|
2020
Q1 | $1.17M | Buy |
+344,026
| New | +$1.5M | ﹤0.01% | 1723 |
|
|
2019
Q2 | – | Sell |
-92,492
| Closed | -$251K | – | 2794 |
|
|
2019
Q1 | $251K | Buy |
+92,492
| New | +$401K | ﹤0.01% | 2528 |
|
|
2018
Q4 | – | Sell |
-473,846
| Closed | -$4.49M | – | 2729 |
|
|
2018
Q3 | $4.49M | Sell |
473,846
-286,941
| -38% | -$2.76M | ﹤0.01% | 1612 |
|
|
2018
Q2 | $7.4M | Buy |
760,787
+386,834
| +103% | +$4.08M | 0.01% | 1374 |
|
|
2018
Q1 | $3.93M | Buy |
373,953
+144,261
| +63% | +$1.42M | ﹤0.01% | 1634 |
|
|
2017
Q4 | $1.47M | Sell |
229,692
-2,943
| -1% | -$18.2K | ﹤0.01% | 2118 |
|
|
2017
Q3 | $1.78M | Buy |
+232,635
| New | +$1.55M | ﹤0.01% | 2048 |
|
|
2014
Q3 | – | Sell |
-46,000
| Closed | -$545K | – | 2381 |
|
|
2014
Q2 | $545K | Buy |
46,000
+9,000
| +24% | +$113K | ﹤0.01% | 1561 |
|
|
2014
Q1 | $552K | Sell |
37,000
-18,000
| -33% | -$284K | ﹤0.01% | 1563 |
|
|
2013
Q4 | $807K | Buy |
55,000
+15,000
| +38% | +$231K | ﹤0.01% | 1439 |
|
|
2013
Q3 | $681K | Buy |
40,000
+11,000
| +38% | +$193K | ﹤0.01% | 1449 |
|
|
2013
Q2 | $481K | Buy |
+29,000
| New | +$470K | ﹤0.01% | 1488 |
|
Other funds holding IMGN
Allianz Asset Management's IMGN Position: Q1 2024 in Review
Allianz Asset Management sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 214,350 shares — an estimated $6.36M sold.
Allianz Asset Management first reported a position in IMGN in Q2 2013 and held it in 27 quarters. The position peaked at $7.4M in Q2 2018. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.
- Allianz Asset Management reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
- Allianz Asset Management sold 214,350 Immunogen Inc shares in Q1 2024, an estimated $6.36M.
- Allianz Asset Management first reported a position in Immunogen Inc in Q2 2013 and held it in 27 quarters.
- Allianz Asset Management's Immunogen Inc position peaked at $7.4M in Q2 2018.
- 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.
Based on Allianz Asset Management's 13F filing for Q1 2024, filed 14 May 2024.